Staar Surgical STAA
$25.21 −$1.51 (-5.65%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $24.72 -1.94%
Open$26.41
Prev close$26.72
Day range$25.06 – $26.70
Volume1.04M
Market cap$1.27B
P/E (TTM)2,521.0
Dividend yield–
STAA Stock News
Headlines matching Staar Surgical or the STAA ticker, most recent first.
- Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $31
- Stifel Upgrades Staar Surgical(STAA.US) to Buy Rating, Raises Target Price to $31 Positive
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of STAAR Surgical Company (NASDAQ: STAA). Negative
- Jefferies Initiates Staar Surgical(STAA.US) With Hold Rating, Announces Target Price $23
- Stifel Maintains Staar Surgical(STAA.US) With Hold Rating, Cuts Target Price to $28 Negative
- Needham Maintains Staar Surgical(STAA.US) With Hold Rating
- Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Nephros (NEPH) and Acrivon Therapeutics, Inc. (ACRV)
- Piper Sandler Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $33
- Wedbush Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $40
- A Quick Look at Today's Ratings for Staar Surgical(STAA.US), With a Forecast Between $32 to $33
- A Quick Look at Today's Ratings for Staar Surgical(STAA.US), With a Forecast Between $31 to $40
- Wedbush Initiates Staar Surgical(STAA.US) With Hold Rating, Announces Target Price $26
- CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $22
- Mizuho Securities Maintains Staar Surgical(STAA.US) With Hold Rating, Raises Target Price to $22 Positive
- Morgan Stanley Maintains Staar Surgical(STAA.US) With Sell Rating, Maintains Target Price $13
No comments yet — be the first to weigh in on STAA.
Sign in to join the discussion.